Relapse in schizophrenia: costs, clinical outcomes and quality of life.

@article{Almond2004RelapseIS,
  title={Relapse in schizophrenia: costs, clinical outcomes and quality of life.},
  author={Stephen Almond and Martin Knapp and Cl{\'e}ment François and Mondher Toumi and Traolach S. Brugha},
  journal={The British journal of psychiatry : the journal of mental science},
  year={2004},
  volume={184},
  pages={
          346-51
        }
}
BACKGROUND Relapse is one of the most costly aspects of schizophrenia. AIMS To compare costs, clinical outcomes and quality of life for patients who experienced relapse in schizophrenia with a control group who did not relapse. METHOD Patients were randomly selected from current psychiatric case-loads drawn from urban and suburban areas of Leicester. Differences in costs and outcomes by relapse status in the previous 6 months were examined using parametric and non-parametric tests, and… CONTINUE READING